113P Pembrolizumab in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors: An update of the phase II KEYNOTE-158 trial
| Autor: | Maio, M., Ascierto, P.A., Motola Kuba, D., Penel, N., Cassier, P.A., Bariani, G.M., De Jesus-Acosta, A., Doi, T., Longo Muñoz, F., Miller, W.H., Oh, D-Y., Gottfried, M., Yao, L., Jin, F.J., Gozman, A., Marabelle, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S589-S590 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|